Alar Pharmaceuticals Inc. (6785.TWO)

TWD 120.0

(0.42%)

EBITDA Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual EBITDA in 2023 was 394.52 Million TWD , up 1446.03% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly EBITDA in 2024 Q2 was 9.1 Million TWD , down -46.49% from previous quarter.
  • Alar Pharmaceuticals Inc. reported an annual EBITDA of -29.31 Million TWD in 2022, up 51.83% from previous year.
  • Alar Pharmaceuticals Inc. reported an annual EBITDA of -60.85 Million TWD in 2021, up 56.51% from previous year.
  • Alar Pharmaceuticals Inc. reported a quarterly EBITDA of 18.68 Million TWD for 2024 Q1, down -95.52% from previous quarter.
  • Alar Pharmaceuticals Inc. reported a quarterly EBITDA of 416.83 Million TWD for 2023 Q4, up 21178.0% from previous quarter.

Annual EBITDA Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual EBITDA of Alar Pharmaceuticals Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 394.52 Million TWD 1446.03%
2022 -29.31 Million TWD 51.83%
2021 -60.85 Million TWD 56.51%
2020 -139.92 Million TWD -136.79%
2019 -59.09 Million TWD 0.0%

Peer EBITDA Comparison of Alar Pharmaceuticals Inc.

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD -92.644%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD -70.718%
Easywell Biomedicals, Inc. -85.5 Million TWD 561.422%
TTY Biopharm Company Limited 1.52 Billion TWD 74.119%
Synmosa Biopharma Corporation 1 Billion TWD 60.89%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 32.322%
Center Laboratories, Inc. -175.17 Million TWD 325.221%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD -1170.678%
Orient Pharma Co., Ltd. 172.39 Million TWD -128.847%
InnoPharmax Inc. -62.12 Million TWD 735.093%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD -211.435%
Excelsior Biopharma Inc. -29.36 Million TWD 1443.321%
DV Biomed Co., Ltd. 407.64 Million TWD 3.219%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 143.251%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 50.856%
UniPharma Co., Ltd. -16.25 Million TWD 2527.218%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD -200.449%
Winston Medical Supply Co., Ltd. 228.32 Million TWD -72.789%
Mercury Biopharmaceutical Corporation -39.03 Million TWD 1110.709%
Bioray Biotech Co., Ltd 12.13 Million TWD -3151.092%
TSH Biopharm Corporation Limited 99.35 Million TWD -297.101%